MD Anderson Cancer Center/University of Texas MD Anderson CC — Houston, Texas

MD Anderson Cancer Center/University of Texas MD Anderson CC is a clinical research site located in Houston, Texas, United States 77030.

Crixeo Health Trust Score: 59/100 (POOR). This profile has not yet been claimed by the site owner.

MD Anderson Cancer Center/University of Texas MD Anderson CC has participated in 2 clinical trials.

Therapeutic areas: Relapsed and Bortezomib Refractory Multiple Myeloma, Refractory Multiple Myeloma, Multiple Myeloma in Relapse.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 59/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for MD Anderson Cancer Center/University of Texas MD Anderson CC?

MD Anderson Cancer Center/University of Texas MD Anderson CC has a Crixeo Trust Score of 59/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has MD Anderson Cancer Center/University of Texas MD Anderson CC conducted?

MD Anderson Cancer Center/University of Texas MD Anderson CC has 2 clinical trials on record. Their work covers Relapsed and Bortezomib Refractory Multiple Myeloma, Refractory Multiple Myeloma, Multiple Myeloma in Relapse.

Is MD Anderson Cancer Center/University of Texas MD Anderson CC accredited by Crixeo Health?

MD Anderson Cancer Center/University of Texas MD Anderson CC has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about MD Anderson Cancer Center/University of Texas MD Anderson CC?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.